Product Program year 2020 Source: CMS Open Payments

Cobas Instruments & Reagents

Device Molecular Diagnostics

Open in the dashboard

General payments

$766,477

90 payments

Research payments

$13,611,002

485 payments

Through program year 2020, $766,477 in general payments and $13,611,002 in research payments were reported against Cobas Instruments & Reagents (Molecular Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $698,974 48
2020 Research $2,704,671 190
2019 General $67,503 42
2019 Research $10,906,331 295

Breakdown

Who paid General payments · program years 2019–2020
  1. Roche Molecular Systems, Inc. $766,477 90 payments
Top recipients General payments · program year 2020
  1. Lawrence Loeb Internal Medicine · Bellevue, WA $432,392 62% · 1 payment
  2. Lance Peterson Clinical Pathology/Laboratory Medicine · Evanston, IL $111,000 16% · 1 payment
  3. Carolyn Kay Obstetrics & Gynecology · Edmonds, WA $105,549 15% · 28 payments
  4. Massachusetts General Hospital Teaching hospital · MA $19,270 3% · 2 payments
  5. University Of Washington Med Ctr Teaching hospital · WA $10,000 1% · 1 payment

The top 5 of 12 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Internal Medicine $432,392 65% · 1 practitioner
  2. Clinical Pathology/Laboratory Medicine Pathology $111,000 17% · 1 practitioner
  3. Obstetrics & Gynecology $105,549 16% · 1 practitioner
  4. Infectious Disease Internal Medicine $5,376 <1% · 2 practitioners
  5. Pediatrics $3,736 <1% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Washington $547,942 78% · 3 recipients
  2. Illinois $111,000 16% · 1 recipient
  3. Massachusetts $19,270 3% · 1 recipient
  4. Michigan $8,596 1% · 2 recipients
  5. California $8,072 1% · 3 recipients

The top 5 of 7 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

90 general · 485 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record